MyoKardia (MYOK) PT Raised to $121 at Morgan Stanley
Tweet
Share
E-mailGet Alerts MYOK Hot Sheet
Price: $224.91 --0%
Rating Summary:
4 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 17
Rating Summary:
4 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 17
Join SI Premium – FREE
Morgan Stanley analyst Jeffrey Hung raised the price target on MyoKardia (NASDAQ: MYOK) to $121.00 (from $117.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Morgan Stanley Upgrades DNB ASA (DNB:NO) (DNHBY) to Equalweight
- Citi Downgrades REA Group Ltd. (REA:AU) (RPGRY) to Neutral
- JPMorgan Downgrades Huaxia Bank Co Ltd (600015:CH) to Underweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
